Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alan Meds vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Alan Meds

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Format
Visit Alan Meds
6.8

NowPatient

Best for Brand-name GLP-1 access without a compounded route
★★★☆☆3.4

Starting at $1069/mo

Brand NameFree Consultation
Visit NowPatient

Side-by-Side Comparison

FeatureAlan MedsNowPatient
Overall Score7.7/106.8/10
Starting Price$99/mo$1069/mo
Editorial Rating3.9 ★ /53.4 ★ /5
Features5 features2 features
States Available460
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alan Meds

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Cons

  • Limited public information on program details

NowPatient

Pros

  • Free telehealth consultation — patients only pay the medication cost
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few telehealth platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand

Cons

  • Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
  • Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
  • State availability not disclosed publicly — determined during intake
  • Phone: 1-866-967-1977, HQ Austin TX
  • Does NOT offer Foundayo (orforglipron)

Our Verdict

Winner: Alan MedsScore: 7.7/10

Alan Meds edges out NowPatient with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.